0001127602-21-004586.txt : 20210209
0001127602-21-004586.hdr.sgml : 20210209
20210209132635
ACCESSION NUMBER: 0001127602-21-004586
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210208
FILED AS OF DATE: 20210209
DATE AS OF CHANGE: 20210209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Baldasare Bryan T
CENTRAL INDEX KEY: 0001761920
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-14902
FILM NUMBER: 21605338
MAIL ADDRESS:
STREET 1: 3471 RIVER HILLS DRIVE
CITY: CINCINNATI
STATE: OH
ZIP: 45244
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MERIDIAN BIOSCIENCE INC
CENTRAL INDEX KEY: 0000794172
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 310888197
STATE OF INCORPORATION: OH
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 3471 RIVER HILLS DR
CITY: CINCINNATI
STATE: OH
ZIP: 45244
BUSINESS PHONE: 5132713700
MAIL ADDRESS:
STREET 1: 3471 RIVER HILLS DRIVE
CITY: CINCINNATI
STATE: OH
ZIP: 45244
FORMER COMPANY:
FORMER CONFORMED NAME: MERIDIAN DIAGNOSTICS INC
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2021-02-08
0000794172
MERIDIAN BIOSCIENCE INC
VIVO
0001761920
Baldasare Bryan T
3471 RIVER HILLS DRIVE
CINCINNATI
OH
45244
1
Exec VP & CFO
Common Stock
2021-02-08
4
M
0
3750
19.56
A
62382
D
Common Stock
2021-02-08
4
S
0
6254
30.00
D
56128
D
Stock Options (Right to Buy)
19.56
2021-02-08
4
M
0
3750
0
D
2026-03-24
Common Stock
3750
0
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 17, 2020.
The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective September 17, 2020.
These non-qualified options were awarded under the 2012 Stock Incentive Plan and vested in four equal installments from the date of grant and were fully vested on March 24, 2020.
/s/ Bryan T. Baldasare
2021-02-09